Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study

OBJECTIVES: To analyse the diagnostic performance of eosinopenia, alone or combined with polymorphonuclear neutrophils (PMN) and/or lymphocytes, as a marker of active COVID-19 in patients hospitalized for suspicion of SARS-CoV-2 infection. METHODS: A prospective observational study including patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Outh, Roderau, Boutin, Caroline, Gueudet, Philippe, Suzuki, Marcelino, Saada, Matthieu, Aumaître, Hugues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792500/
https://www.ncbi.nlm.nih.gov/pubmed/33468435
http://dx.doi.org/10.1016/j.jmii.2020.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792500/
https://www.ncbi.nlm.nih.gov/pubmed/33468435
http://dx.doi.org/10.1016/j.jmii.2020.12.005

Ejemplares similares